FVWA
GSK icon

Foster Victor Wealth Advisors’s GSK GSK Stock Holding History

Foster Victor Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2M Buy
414,286
+19,691
+5% +$1.04M 1.12% 22
2026
Q1 		$23.4M Buy
394,595
+3,390
+0.9% +$184K 1.33% 15
2025
Q4 		$18.9M Buy
391,205
+5,733
+1% +$267K 1.1% 25
2025
Q3 		$16.7M Buy
385,472
+21,778
+6% +$851K 1.04% 38
2025
Q2 		$14.2M Buy
363,694
+11,383
+3% +$435K 0.96% 45
2025
Q1 		$12.2M Buy
352,311
+51
+0% +$1.87K 0.98% 48
2024
Q4 		$11.8M Buy
352,260
+79,343
+29% +$2.86M 0.9% 52
2024
Q3 		$11M Buy
272,917
+13,045
+5% +$534K 0.88% 51
2024
Q2 		$10.1M Buy
259,872
+43,422
+20% +$1.83M 0.84% 51
2024
Q1 		$8.83M Buy
216,450
+66,632
+44% +$2.75M 0.81% 60
2023
Q4 		$5.94M Buy
149,818
+5,818
+4% +$209K 0.61% 61
2023
Q3 		$5.28M Buy
144,000
+4,034
+3% +$143K 0.61% 62
2023
Q2 		$4.86M Buy
139,966
+7,588
+6% +$272K 0.54% 64
2023
Q1 		$4.84M Buy
132,378
+6,372
+5% +$223K 0.59% 60
2022
Q4 		$4.4M Sell
126,006
-535
-0.4% -$17.8K 0.56% 63
2022
Q3 		$3.8M Buy
126,541
+32,612
+35% +$1.24M 0.55% 63
2022
Q2 		$5.06M Buy
93,929
+1,908
+2% +$105K 0.75% 56
2022
Q1 		$5.26M Buy
92,021
+12,296
+15% +$668K 0.72% 56
2021
Q4 		$4.51M Buy
79,725
+14,737
+23% +$767K 0.61% 61
2021
Q3 		$3.1M Buy
64,988
+9,905
+18% +$498K 0.5% 62
2021
Q2 		$2.74M Buy
55,083
+15,027
+38% +$722K 0.46% 70
2021
Q1 		$1.8M Buy
40,056
+19,064
+91% +$865K 0.34% 80
2020
Q4 		$966K Buy
20,992
+9,702
+86% +$446K 0.22% 84
2020
Q3 		$531K Buy
11,290
+6,254
+124% +$313K 0.14% 92
2020
Q2 		$257K Buy
+5,036
New +$258K 0.09% 103

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Foster Victor Wealth Advisors's GSK Position: Q2 2026 in Review

Foster Victor Wealth Advisors increased its GSK (GSK) stake by 5% in Q2 2026, buying an estimated $1.04M and bringing the position to 414,286 shares worth $21.2M. The position accounts for 1.12% of the portfolio, ranked #22.

Foster Victor Wealth Advisors first reported a position in GSK in Q2 2020 and has held it in 25 quarters since. The position peaked at $23.4M in Q1 2026. 1,038 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Foster Victor Wealth Advisors held 414,286 shares of GSK worth $21.2M as of Q2 2026.
  • Foster Victor Wealth Advisors bought 19,691 GSK shares in Q2 2026, an estimated $1.04M.
  • GSK made up 1.12% of Foster Victor Wealth Advisors's portfolio in Q2 2026, its #22 holding.
  • Foster Victor Wealth Advisors first reported a position in GSK in Q2 2020 and has held it in 25 quarters since.
  • Foster Victor Wealth Advisors's GSK position peaked at $23.4M in Q1 2026.
  • 1,038 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Foster Victor Wealth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.